Howmet Aerospace (HWM)
NYSE MKTIndustrialsAerospace & DefenseSnapshot 2026-11-04
$213.56-4.28%
Close 2026-11-04 · 1-day change
NYSE MKTIndustrialsAerospace & DefenseSnapshot 2026-11-04
Research Workspace
Put HWM beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Aerospace & Defense is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is accelerating — up about 22% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskHealthy across the board
Howmet's aerospace demand has to keep compounding to justify the price. Revenue growth is accelerating, hitting 29% year over year in Q3. The company beat its earnings estimate by 6.6% last quarter. It trades at 42 times earnings versus a 29 times peer median. The price reflects less growth than our forecast suggests. A 17% drop from its recent high signals a thesis repricing. The 42 times multiple is a premium that must be earned. Peer multiples imply a price about 10% below where it trades. Our read remains intact.
Trailing returns as of 2026-11-04. HWM is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 23 analysts currently covering HWM (as of Nov 2026).
Based on 8 Wall Street analysts offering 12-month price targets for HWM in the last 4 months.
Continue this research
Compare HWM with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| HWM Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Aerospace & Defense — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put HWM next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Achieve approximately 10% revenue growth in 2026
Q3 beat and raised outlook support growth and the 2026 revenue target; details are needed to assess durability.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $213.56
The last 12 months of price, then the range of analyst 12-month targets from today’s $213.56.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Achieve approximately 10% revenue growth in 2026
2027 growth outlook and higher 2026 free cash flow reinforce growth and capital-allocation objectives.
Advances: Achieve approximately 10% revenue growth in 2026
Official earnings-call commentary is a material update on growth, cash flow, and guidance objectives.
Advances: Achieve approximately 10% revenue growth in 2026
Reported 2027 sales outlook above forecasts supports growth objectives and indicates stronger-than-expected momentum.
Advances: Achieve approximately 10% revenue growth in 2026
Q3 beat and higher 2026 guidance reinforce growth objectives; $5B buyback signals strong cash generation and capital allocation.
Increased competition may hinder revenue growth objectives.
Increased demand supports revenue growth objectives.
SpaceX's actions may impact Howmet's competitive position.
